Tarsus Pharmaceuticals commercial chief leaves company

The departure of the head of the commercial division at Tarsus Pharmaceuticals may lead to uncertainties due to changes in management.

AI CATALYST SCORE25 / 100Score computed by Sentinel V12

REFERENCE PRICENot measuredReference entry price at analysis time

ANALYSIS HISTORY

TRMD Analysis History (Last 30 Days)

Diagnosed At	Ticker	AI Score	Tier
2026-08-26 14:49:49	TRMD	50	Row	View Report →
2026-08-26 10:36:30	TRMD	75	Mid	View Report →
2026-08-26 07:42:44	TRMD	50	Row	View Report →

RELATED REPORTS

Diagnosed At	Ticker	AI Score	Tier
2026-08-31 02:17:58	OKE	85	Mid	View Report →
2026-08-30 20:50:21	OKE	75	Mid	View Report →
2026-08-30 12:46:28	XOM	75	Mid	View Report →
2026-08-29 01:22:24	KNTK	40	Row	View Report →
2026-08-28 18:45:43	ENB	75	Mid	View Report →
2026-08-28 15:12:51	FRO	85	Mid	View Report →
2026-08-28 14:02:20	CVX	75	Mid	View Report →
2026-08-28 13:42:41	PBR	75	Mid	View Report →
2026-08-28 12:15:28	MTDR	65	Mid	View Report →
2026-08-27 19:38:04	BWXT	85	Mid	View Report →
2026-08-27 17:58:10	STDN	85	S-Class	View Report →
2026-08-27 17:37:42	FRO	50	Row	View Report →
2026-08-27 16:05:02	TTE	75	Mid	View Report →
2026-08-27 15:22:51	BP	50	Row	View Report →
2026-08-27 15:18:03	CMBT	80	Mid	View Report →
2026-08-27 13:43:56	TE	85	S-Class	View Report →
2026-08-27 13:29:29	BWXT	75	Mid	View Report →
2026-08-26 19:00:24	DTM	85	S-Class	View Report →
2026-08-26 18:31:42	SEDG	85	S-Class	View Report →
2026-08-26 17:38:41	CMBT	30	Row	View Report →
2026-08-26 13:48:22	NXXT	85	S-Class	View Report →
2026-08-26 11:17:08	ENB	75	Mid	View Report →
2026-08-25 16:37:00	RIG	50	Row	View Report →
2026-08-25 16:03:54	COP	50	Row	View Report →
2026-08-25 13:23:39	CBAT	85	S-Class	View Report →
2026-08-24 18:43:29	XOM	40	Row	View Report →
2026-08-24 13:19:48	KRP	75	Mid	View Report →
2026-08-24 06:14:37	XOM	40	Row	View Report →
2026-08-22 11:26:27	WKC	85	Mid	View Report →
2026-08-21 17:51:25	LEU	75	Mid	View Report →